Matinas BioPharma Holdings (MTNB) Nominates Kathryn Penkus Corzo for its Board of Members
Matinas BioPharma Holdings (NYSEAMERICAN:MTNB), a clinical-stage biopharmaceutical company, dedicated to enhancing intracellular delivery of critical therapeutics via its cutting edge lipid nanocrystal (LNC) platform delivery technology, has just nominated Kathryn Penkus Corzo to stand for election to the Company’s Board of Directors. The election is scheduled to take place at the 2021 Annual Meeting of Stockholders on November 1, 2021. As of now, Ms. Corzo is a partner at Takeda…